about
Gene therapy in Parkinson's disease: rationale and current statusTheoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's DiseaseExperimental therapeutics for dystonia.alpha-Synuclein: a therapeutic target for Parkinson's disease?Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.Replacement of huntingtin exon 1 by trans-splicing.Can parkin be a target for future treatment of Parkinson's disease?
P2860
Q22241423-2A3CE7C7-4077-4D3C-9596-FD37ABBD33E3Q26746174-C691F706-1090-4C32-97BE-D172136D8A20Q36569704-C1E350FD-ECD7-4BD2-80DD-82D112245BC4Q37070916-57EB1999-15FA-4E72-9AC9-FF009BD27DF5Q37302816-B404BF03-6CFA-443D-81A8-9BE7836F41AFQ37418724-47F28920-911B-4A18-96E3-9FDF96E5E160Q38127703-3B3DE884-2677-4218-A7AF-5477D5A74D81
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Advances in gene therapy for movement disorders.
@ast
Advances in gene therapy for movement disorders.
@en
Advances in gene therapy for movement disorders.
@nl
type
label
Advances in gene therapy for movement disorders.
@ast
Advances in gene therapy for movement disorders.
@en
Advances in gene therapy for movement disorders.
@nl
prefLabel
Advances in gene therapy for movement disorders.
@ast
Advances in gene therapy for movement disorders.
@en
Advances in gene therapy for movement disorders.
@nl
P2860
P1433
P1476
Advances in gene therapy for movement disorders
@en
P2093
Hideki Mochizuki
Toru Yasuda
P2860
P2888
P304
P356
10.1016/J.NURT.2008.01.005
P577
2008-04-01T00:00:00Z
P5875
P6179
1050381580